ACAD - acadia-pharm.com Uzoq muddatli majburiyatlarning kapitalga nisbati

ACADIA Corp (ACAD) tovar belgisi

ACADIA Pharmaceuticals (ACAD) o'sishi Daybue ning tijorat muvaffaqiyatiga, Nuplazid ga bo'lgan talabga va kam uchraydigan psixiatrik kasalliklar uchun yangi yechimlarni izlashga bog'liq. Yuqori R&D xarajatlari va FDA ning qat'iy nazorati kichik ishtirokchilarni chetga surib, bozor nishasining himoyasini ta'minlaydi. Ko'rsatkich 0.05 hisoblanadi. Qimmatli qog'ozlarning narx dinamikasi patent himoyasining ta'sirini va qat'iy tartibga soluvchi muhitdagi kompaniyaning lobbi imkoniyatlarini tasdiqlaydi.

ACAD - ACADIA Pharma Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022 - 29.10.2026 oraligʻida
ACADIA Pharmaceuticals asosiy tovari

ACADIA Pharmaceuticals (ACAD) nevrologik dori vositalari ishlab chiqarishni kengaytirayotgan biotexnologiya sektori uchun qarz va kapital o'rtasidagi muvozanat hal qiluvchi ahamiyatga ega. Ushbu uzoq muddatli moliyaviy qaramlik koeffitsiyenti bir yildan ortiq muddatga ega majburiyatlarni umumiy kapital bilan solishtirib, leveraj darajasini va balans strukturasining barqarorligini belgilaydi.

Muhim raqobatchilar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|xenon-pharma.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Viking Therapeutics, Inc. (VKTX)|SUPN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CPRX|Denali Corp (DNLI) - Uzoq muddatli majburiyatlarning kapitalga nisbati|HRMY (Harmony Biosciences) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati biohavenpharma.com|Uzoq muddatli qarzning kapitalga nisbati AMLX (Amylyx Pharmaceuticals, Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Therapeutics Inc (TRVI)|Uzoq muddatli qarzning kapitalga nisbati PRAX (Praxis Medicines)|Uzoq muddatli qarzning kapitalga nisbati Anavex Life Sciences Corp AVXL|CeriBell, Inc. (CBLL) - Uzoq muddatli qarzning kapitalga nisbati|PRTA - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|alector.com - Uzoq muddatli qarzning kapitalga nisbati|Annexon Biosciences (ANNX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|OMER (Omeros Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Neurogene Therapeutics (NGNE)|AC Immune (ACIU) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VYGR (voyagertherapeutics.com)|Neumora Therapeutics, Inc. (NMRA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati Scilex Holding SCLX|Uzoq muddatli qarzning kapitalga nisbati Tevogen Bio Holdings, Inc. (TVGN)|ACOG - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CGTX: Uzoq muddatli qarzning kapitalga nisbati|IKT (inhibikase.com) - Uzoq muddatli qarzning kapitalga nisbati|SAVA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ASRT|Uzoq muddatli qarzning o'z kapitaliga nisbati COYA (Coya Therapeutics, Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati vistagen.com (VTGN)|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati acumenpharm.com ABOS|CRVO: Uzoq muddatli qarzning kapitalga nisbati|ATHE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati CLNN|Uzoq muddatli majburiyatlarning kapitalga nisbati PepGen|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati relmada.com (RLMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio|Uzoq muddatli kreditlarning kapitalga nisbati gracetx.com (GRCE)|Uzoq muddatli qarzning kapitalga nisbati AIFF|Uzoq muddatli qarzdorlikning kapitalga nisbati ANEW Medical KLTO|NRSN: Uzoq muddatli qarzning kapitalga nisbati|RVPH - Uzoq muddatli qarzning o'z kapitaliga nisbati|MTVA: Uzoq muddatli qarzning kapitalga nisbati|NRXS (NeurAxis Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati PASG|NEUP (Neuphoria Therapeutics Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com (NERV)|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|Uzoq muddatli qarzning kapitalga nisbati Addex Therapeutics Ltd. ADXN|ALZN: Uzoq muddatli qarzning kapitalga nisbati|CYCN - Uzoq muddatli qarzning o'z kapitaliga nisbati|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Pasithea Therapeutics Corp. (KTTA) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Cortigent Inc (CRGT)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Cara Therapeutics Inc (CARA)|CHRO: Uzoq muddatli qarzning kapitalga nisbati|ELYM - Uzoq muddatli majburiyatlarning kapitalga nisbati|Intra-Cellular - Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Marinus MRNS|NKGN (NKGen Biotech Corp) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO (NeuroBo Pharmaceuticals)|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning kapitalga nisbati Trevena Inc. (TRVN)|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Anew Medical Inc. WENA|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati